Symbol: |
ERCC1
|
Description: |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) [Source:HGNC Symbol;Acc:3433]
|
Location: |
Chr19:45910591-45982086[-]
|
CRmiRSNP:
~ Export ~
|
Records:618
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:42 Current:1
[First] [Prev]  Next Last 
|
Compound:
~ Export ~
|
Records:270
Gene |
Compound |
Gen_sig |
Exp_pattern |
ERCC1 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- |
0.045 |
Up |
ERCC1 |
1H-Pyrazole-1-ethanol, 4,4'-azoxybis(3,5-dimethyl- |
0.019 |
Up |
ERCC1 |
Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- |
0.03 |
Up |
ERCC1 |
TETRAAMMINECOPPER(2+) DITHIOCYANATE COMPOUND WITH QUINOLINE THIOCYANATE (1:3) |
0.036 |
Down |
ERCC1 |
1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- |
0.001 |
Up |
ERCC1 |
NSC 201902 |
0.004 |
Up |
ERCC1 |
1,8-Octanediamine, N,N'-di-9-acridinyl- |
0.017 |
Up |
ERCC1 |
NSC 23416 |
0.043 |
Up |
ERCC1 |
Viridomycin |
0.001 |
Up |
ERCC1 |
1H-Pyrazole-5-carboxylic acid, 4,5-dihydro-1,3-diphenyl-, potassium salt |
0.002 |
Up |
ERCC1 |
Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester |
0.003 |
Up |
ERCC1 |
2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- |
0.025 |
Up |
ERCC1 |
NSC 26112 |
0.028 |
Up |
ERCC1 |
6-Benzylthioinosine |
0.007 |
Up |
ERCC1 |
NANAOMYCIN |
0.046 |
Up |
Expression pattern: Sensitivity / Resistance
Total:18 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:90
Total:6 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:24
Total:2 Current:1
[First] [Prev]  Next Last 
|